Exploring the dangerous partnership between estrogen and VEGF in premenopausal breast cancer and how this discovery is revolutionizing treatments.
Discover how XRCC1 genetic variations can predict chemotherapy response in breast cancer patients, advancing personalized cancer medicine.
Exploring the complex relationship between timing of oral contraceptive use and breast cancer risk, with data visualizations and risk analysis.
Explore how mTOR inhibitors are revolutionizing breast cancer treatment by targeting cellular pathways in resistant cancers, with insights into drug mechanisms and future therapies.
Discover how Stat5 protein acts as a tumor suppressor in breast cancer, inhibiting invasion and aggressive growth through groundbreaking research.
Comprehensive analysis of hormone replacement therapy and breast cancer risk, including research findings, clinical implications, and alternative treatments.
Breakthrough in triple-negative breast cancer treatment using LHRH peptide-decorated cross-linked micelles for targeted drug delivery
Exploring how short-term, high-dose estrogen exposure can permanently reprogram mammary tissue to resist carcinogenesis while long-term exposure increases risk.
Exploring the molecular interplay between estrogen receptors and growth factors in breast cancer development and treatment resistance.
Discover how SCN3B, a voltage-gated sodium channel subunit, acts as a powerful metastasis suppressor in breast cancer by inhibiting cell migration and invasion.